Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of TTR-CA in HFpEF Community Study
NCT03414632Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2017
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Prevalence of Transthyretin Cardiac Amyloidosis. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03414632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414632.